The pharmacology of ion channels:: with particular reference to voltage-gated Ca2+ channels

被引:82
作者
Triggle, DJ [1 ]
机构
[1] SUNY Buffalo, Buffalo, NY 14260 USA
关键词
D O I
10.1016/S0014-2999(99)00329-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ion channels are molecular machines that serve as principal integrating and regulatory devices for the control of cellular excitability. They are also major targets for drug action. The basic aspects of ion channel structure and pharmacological control are reviewed and illustrated with specific reference to a major class of therapeutic agents and molecular tools - the clinically available Ca2+ channel antagonists. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:311 / 325
页数:15
相关论文
共 82 条
[21]   Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture [J].
Docherty, RJ ;
Yeats, JC ;
Piper, AS .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (07) :1461-1467
[22]   Molecular properties of voltage-gated K+ channels [J].
Dolly, JO ;
Parcej, DN .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1996, 28 (03) :231-253
[23]   The structure of the potassium channel:: Molecular basis of K+ conduction and selectivity [J].
Doyle, DA ;
Cabral, JM ;
Pfuetzner, RA ;
Kuo, AL ;
Gulbis, JM ;
Cohen, SL ;
Chait, BT ;
MacKinnon, R .
SCIENCE, 1998, 280 (5360) :69-77
[24]  
Epstein M., 1998, CALCIUM ANTAGONISTS, P553
[25]   BINDING OF A 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL ACTIVATOR, (-) S BAY K-8644, TO CARDIAC PREPARATIONS [J].
FERRANTE, J ;
LUCHOWSKI, E ;
RUTLEDGE, A ;
TRIGGLE, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (01) :149-154
[26]   NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE [J].
FURBERG, CD ;
PSATY, BM ;
MEYER, JV .
CIRCULATION, 1995, 92 (05) :1326-1331
[27]   Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine [J].
Furukawa, T ;
Nukada, T ;
Suzuki, K ;
Fujita, Y ;
Mori, Y ;
Nishimura, M ;
Yamanaka, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (06) :1136-1140
[28]   CARDIOSELECTIVITY OF CALCIUM-ANTAGONISTS [J].
GODFRAIND, T .
CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 :353-364
[29]  
GODFRAIND T, 1968, Therapie (London/Paris), V23, P1209
[30]   SELECTIVITY SCALE OF CALCIUM-ANTAGONISTS IN THE HUMAN CARDIOVASCULAR-SYSTEM BASED ON INVITRO STUDIES [J].
GODFRAIND, T ;
SALOMONE, S ;
DESSY, C ;
VERHELST, B ;
DION, R ;
SCHOEVAERTS, JC .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S34-S41